1-O-octadecyl-2-O-methylglycero-3-phosphocholine (Edelfosine) and cancer cell invasion: A short review

Anti-Cancer Agents in Medicinal Chemistry

Volumn 14, Issue 4, 2014, Pages 539-544

  van Slambrouck, Séverine ^a,b   Steelant, Wim F A ^a,b  

^a NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^b ST THOMAS UNIVERSITY   (United States)

Author keywords

2 lysophosphatidylcholine; Alkyllysophospholipids; Edelfosine; Glycosylation; Invasion; Signal transduction

Indexed keywords

BETA CATENIN; EDELFOSINE; GELATINASE A; GELATINASE B; MUCIN 1; SIALIC ACID; SIALYLTRANSFERASE; UVOMORULIN; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER INHIBITION; CELL INVASION; DRUG MECHANISM; DRUG TARGETING; HUMAN; NONHUMAN; REVIEW; SIALYLATION;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; PHOSPHOLIPID ETHERS; SIGNAL TRANSDUCTION;

EID: 84908130033     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520614666140309231505     Document Type: Review

References (55)

1. Voet, D.; Voet, J.G. Biochemistry, 4th ed.; Wiley & Sons: New York, 2010.
2. Fischer, H. Lysolecithin and the action of complement. Ann. N.Y. Acad. Sci., 1964, 116, 1063-1070.
3. Munder, P.G.; Ferber, E.; Modolell, M.; Fischer, H. The influence of various adjuvants on the metabolism of phospholipids in macrophages. Int. Arch. Allergy, 1969, 36, 117-128.
4. Stein, Y.; Stein, O. Metabolism of labeled lysolecithin, lysophosphatidyl ethanolamine and lecithin in the rat. Biochem. Biophys. Acta, 1966, 116, 95-107.
5. Webster, G.R. The acylation of lysophophatides with long-chain fatty acids by brain and other tissues. Biochem. Biophys. Acta, 1965, 98, 512-519.
6. Arnold, D.; Weltzien, H.W.; Westphal, O. Synthesen von cholinphosphatiden. III. Uber die synthese von lysolecithinen und ihren Ather-analoga. Liebigs Ann. Chem., 1967, 709, 234-239.
7. Eibl, H.J.; Arnold, D.; Weltzien, H.U.; Westphal, O. Synthesen von cholinphosphatiden. I. Zur synthese von alpha- und beta-lecithinen und ihren atheranaloga. Liebigs Ann. Chem., 1967, 709, 226-230.
8. Munder, P.G.; Weltzien, H.U.; Modolell, M. In: Lysolecithin analogs: A new class of immunopotentiators; Immunopathology, ed.; Miescher P.A.: Grune & Stratton: New York, San Francisco, London, 1976, Vol. 7, pp 411-424.
9. Andreesen, R.; Modolell, M.; Weltzien, H.U.; Eibl, H.; Common, H.H.; Lohr, G.W.; Munder, P.G. Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Res., 1978, 38, 3894-3899.
10. Andreesen, R.; Modolell, M.; Munder, P.G. Selective sensitivity of chronic myelogenous leukemia cell populations to alkyl-lysophospholipids. Blood, 1979, 54, 519-523.
11. Modolell, M.; Andreesen, R.; Pahlke, W.; Brugger, U.; Munder, P.G. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids. Cancer Res., 1979, 39, 4681-4686.
12. Berdel, W.E.; Bausert, W.R.; Weltzien, H.U.; Modolell, M.; Widmann, K.H.; Munder, P.G. The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma. Eur. J. Cancer, 1980, 16, 1199-1204.
13. Tarnowski, G.S.; Mountain, I.M.; Stock, C.C.; Munder, P.G.; Weltzien, H.U.; Westphal, O. Effect of lysolecithin and analogs on mouse ascites tumors. Cancer Res., 1978, 38, 339-344.
14. Berger, M.R.; Munder, P.G.; Schmahl, D.; Westphal, O. Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas. Oncology, 1984, 41, 109-113.
15. Scherf, H.R.; Schuler, B.; Berger, M.R.; Schmahl, D. Therapeutic activity of ET-18-OCH3 and hexadecylphosphocholine against mammary tumors in BD-VI rats. Lipids, 1987, 22, 927-929.
16. Berger, M.R.; Schmahl, D. Protection by the alkyllysophospholipid, 1-O-octadecyl-2-O-methoxy-rac glycero-3-phosphocholine, but not by the retinoid etretinate against leukemia development in DMBA-treated Long-Evans rats. Cancer Lett., 1986, 30, 73-78.
17. Santos, G.W.; Colvin, M.O. Pharmacological purging of bone marrow with reference to autografting. Clin. Haemathol., 1986, 15, 67-83.
18. Vogler, W.R. Bone marrow purging in acute leukemia with alkyl-lysophospholipids: A new family of anticancer drugs. Leuk. Lymphoma, 1994, 13, 53-60.
19. Vogler, W.R.; Berdel, W.E.; Geller, R.B.; Brochstein, J.A.; Beveridge, R.A.; Dalton, W.S.; Miller, K.B.; Lazarus, H.M. A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow. Adv. Exp. Med. Biol., 1996, 416, 389-396.
20. Yilmaz, M.; Christofori, G. Mechanisms of motility in metastasizing cells. Mol. Cancer Res., 2010, 8, 629-642.
21. Berdel, W.E.; Schlehe, H.; Fink, U.; Emmerich, B; Maubach, P.A.; Emslander, H.P.; Daum, S.; Rastetter, J. Early tumor and leukemia response to alkyllysophospholipids in a phase I study. Cancer, 1982, 50, 2011-2015.
22. Munder, P.G.; Modolell, M.; Bausert, W.; Oettgen, H.F.; Westphal, O. In: Alkyl-lysophospholipids in cancer therapy. Augmenting agents in cancer therapy. Progress in cancer research therapy 16; Hersch, E.M.; Chirigos, M.A.; Mastrangelo, M.J., Eds.; Raven Press: New York, 1981, pp. 441-458.
23. Storme, G.A.; Berdel, W.E.; Van Blitterswijk, W.J.; Bruyneel, E.A.; De Bruyne, G.K.; Mareel, M.M. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Cancer Res., 1985, 45, 351-357.
24. Storme, G.A.; Bruyneel, E.A.; Schallier, D.C.C., Bolscher, J.G.; Berdel, W.E.; Mareel, M.M. Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types. Lipids, 1987, 22, 847-850.
25. Engebraaten, O.; Bjerkvig, R.; Berens, M.E. Effect of alkyllysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. Cancer Res., 1991, 51, 1713-1719.
26. Slaton, J.W.; Hampton, J.A.; Selman, S.H. Exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinoma. J. Urol., 1994, 152, 1594-1598.
27. Haugland, H.K.; Nygaard, S.J.; Tysnes, O.B. Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro. Anticancer Res., 1999, 19, 149-156.
28. Bolscher, J.G.M.; Schallier, D.C.C.; Smets, L.A.; Van Rooy, H.; Collard, J.G.; Bruyneel E.A.; Mareel, M.M. Effect of cancer-related and drug-induced alterations in surface carbohydrates on the invasive capacity of mouse and rat cells. Cancer Res., 1986, 46, 4080-4086.
29. Bruyneel, E.A.; Schallier, D.C.; Bolscher, J.G.; Storme, G.A.; De Mets, M.; Mareel, M.M. In: Effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine (ET-18-OMe) on invasion in vitro and on N-linked surface glycosylation. In: The pharmacological effects of lipids. III: The role of lipids in cancer research. Kabara. J.J., Ed.; The American Oil Chemists Society, AOCS Press: Champaign, 1989, pp. 301-308.
30. Steelant, W.F.A.; Goeman, J.L.; Philippe J., Oomen, L.C.J.M.; Hilkens, J.; Krzewinski-Recchi, M.-A.; Guillemette, H.; Van Der Eycken, J.; Delannoy, P.H.; Bruyneel, E.A.; Mareel, M.M. Alkyllysophospholipid 1-O-octadecyl-2-O-methylgl-glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Int. J. Cancer, 2001, 92, 527-536.
31. Bracke, M.E.; Van Larebeke, N.A.; Vyncke, B.M.; Mareel, M.M. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br. J. Can., 1991, 63, 867-872.
32. Simon, N.; Noel, A.; Foidart, J.M. Evaluation of in vitro reconstituted basement assay to assess the invasiveness of tumor cells. Invasion Metastasis, 1992, 12, 156-167.
33. Lohmeyer, M.; Bittman, R. Antitumor ether lipids and alkylphosphocholines. Drugs of the Future, 1994, 19, 1021-1037.
34. Van Blitterswijk, W.J.; Hilkmann, H.; Storme, G.A. Accumulation of an alkyllysophospholipid in tumor cell membrane affects membrane fluidity and tumor cell invasion. Lipids, 1987, 22, 820-823.
35. Nicholson, G.S. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim. Biophys. Acta, 1982, 695, 113-176.
36. Smets, L.A.; Van Beek, W.P.; Van Rooij, H. Surface glycoproteins and concanavalin-A-mediated agglutination of clonal variants and tumor cells derived from SV40-virus-transformed mouse 3T3 cells. Int. J. Cancer, 1976, 18, 462-468.
37. Bolscher, J.G.M.; Schallier, D.C.C.; Van Rooy, H.; Storme, G.A.; Smets, L.A. Modification of cell surface carbohydrates and invasive behavior by an alkyl-lysophospholipid. Cancer Res., 1988, 48, 977-982.
38. Schallier, D.C.C.; Bruyneel, E.A.; Storme, G.A.; Mareel, M.M. Role of the host tissue in the anti-invasive activity of the alkyllysophospholipid, ET-18-OMe, in vitro. Clin. Exp. Metastasis, 1991, 9, 579-591.
39. Van Slambrouck, S.; Steelant, W.F.; Lopez, M.; Recchi, M.-A.; Boilly-Marer, Y.; Bruyneel, E.A.; Delannoy, P.; Verbert, A.; Van Den Eeckhout, E.G.; Deforce, D. Edelfosine protects precultured heart fragments against the invasion of malignant cells through altered sialylation. Oncol. Rep., 2007, 17, 433-439.
40. Steinberg, M.S. Adhesion-guided multicellular assembly: A commentary on the postulates, real and imagined, of the differential adhesion hypothesis, with special attention to computer simulations of cell sorting. J. Theor. Biol., 1975, 55, 431-443.
41. Van Larebeke, N.A.; Bruyneel, E.A.; Mareel, M.M. An anti-invasive concentration of the alkyl-lysophospholipid ET-18-OCH3 enhances the motility of embryonal chick heart cells cultured on solid substrate. Clin. Exp. Metastasis, 1994, 12, 255-261.
42. Bracke, M.E.; Vyncke, B.M.; Bruyneel, E.A.; Vermeulen, S.J.; De Bruyne, G.K.; Van Larebeke, N.A.; Vleminckx, K.; Van Roy, F.M.; Mareel, M.M. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCf-7 human mammary carcinoma cells in vitro. Br. J. Cancer, 1993, 68, 282-289.
43. Steelant, W.F.; Recchi, M.A.; Noe, V.T.; Boilly-Marer, Y.; Bruyneel, E.A.; Verbert, A.; Mareel, M.M.; Delannoy, P. Sialylation of E-cadherin does not change the spontaneous or ET-18-OMe-mediated aggregation of MCF-7 human breast cancer cells. Clin. Exp. Metastasis, 1999, 17, 245-253.
44. Wesseling, J.; Van der Valk, S.W.; Hilkens J. A mechanism for inhibition of e-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell., 1996, 7, 565-577.
45. Leroy, A.; De Bruyne, G.K.; Oomen, L.L.C.; Mareel, M.M. Alkyllysophospholipids reversibly open epithelial tight junctions. Anticancer Res., 2003, 23, 27-32.
46. Bershadsky, A.; Chausovsky, A.; Becker, E.; Lyubimova, A.; Geiger, B. Involvement of microtubules in the control of adhesion-dependent signal transduction. Curr. Biol., 1996, 6, 1279-1289.
47. Berdel, W.E.; Andreesen, R.; Munder, P.G. Synthetic alkyllysophospholipids analogs: A new class of anti-tumor agents; In: Phospholipids and cellular regulation, ed.; Kuo J.F.: CRC Press: Boca Raton, Florida, 1985, pp. 41-73.
48. Berdel, W.E.; Greiner, E.; Fink, U.; Stavrou, D.; Reichert, A.; Rastetter, J.; Hoffman, D.R.; Snyder, F. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells. Cancer Res., 1983, 43, 541-545.
49. Berdel, W.E.; Greiner, E.; Funk, U.; Zanker, K.S.; Stavrou, D.; Trappe, A.; Fahlbusch, R.; Reichert A.; Rastetter, J. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells. Oncology, 1984, 41, 140-145.
50. Schaller, M.D.; Hildebrand, J.D.; Shannon, J.D.; Fox, J.W.; Vines, R.R.; Parsons, J.T. Auto-phosphorylation of the focal adhesion kinase, pp125FAK, directs SH2 dependent binding of pp60src. Mol. Cell. Biol., 1994, 14, 1680-1688.
51. Bjorklund, M.; Koivunen, E. Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta, 2005, 1755, 37-69.
52. Van Slambrouck, S.; Hilkens, J.; Steelant, W.F. Ether lipid 1-O-octadecyl-2-O-methyl-3-glycero-phosphocholine inhibits cell-cell adhesion through translocation and clustering of E-cadherin and episialin in membrane microdomains. Oncol. Rep., 2008, 19, 123-128.
53. Steelant, W.F.; Kawakami, Y.; Ito, A.; Handa, A.K.; Bruyneel, E.A.; Mareel, M., Hakomori, S. Monosialyl-Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF-7 cells defines their invasive properties. FEBS Lett., 2002, 531, 93-98.
54. Chatzizacharias, N.A.; Kouraklis, G.P.; Theocharis, S.E. Clinical significance of FAK expression in human neoplasia. Histol. Histopathol., 2008, 23, 629-650.
55. Guarino, M. SRC signaling in cancer cell invasion. J. Cell. Physiol., 2010, 223, 14-26.